A phase 1b/2 umbrella study of investigational immune and targeted combination therapies as first-line therapy for patients with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Plimack, E. R.; Hammers, H. J.; Choueiri, T. K.; Rini, B. I.; Motzer, R. J.; Suttner, L.; Perini, R. F.; Rogerio, J. W.; Albiges, L. |
| Abstract Title: | A phase 1b/2 umbrella study of investigational immune and targeted combination therapies as first-line therapy for patients with advanced renal cell carcinoma (RCC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306287 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS4594 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4594 -- Source: Wos |
